Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers
Remdesivir intermediates Pyrrolo[2,1-f][1,2,4]triazin-4-amine (CAS NO. 159326-68-8) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation
Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs developed by Gilead Sciences. In February 2020 Remdesivir was being studied for experimental
treatment of the emergent COVID-19 (novel coronavirus) disease.
Find More Remdesivir Intermediates>>>
I want to comment